Vision without a plan is just a dream. Plan our trades and trade our plans. Business person of the year. Invest in game changers. Using both FA and TA for trading. Equities, ETFs, rarely options.

From February 2013 to April 2014, amassed over 2600% gains. DISCLAIMER: Never follow anyone blindly, including myself. Always do your own DD and have an entry and exit strategy.

President of Gunderson Capital Mgt. Host of nationally syndicated Best Stocks Now Radio Hour. Inventor of Best Stocks Now app. Frequent contributor to Fox, CNBC, Marketwatch & TheStreet.

Economist, Certified Portfolio Manager and Technical analyst. My opinion is not a proposal to Buy, Hold or Sell securities. Please be careful with investments. Trade wisely. Learn from your mistakes and think out of the box.

PhD in the biomedical sciences. Been investing in the biotechnology sector for 20 years focusing on capturing the big gains.

The premier destination for both new or experienced active traders who are looking for stock picks, stock ideas, how to get started trading stocks, and overall stock market education.

Formerly Bear Stearns then co-founded a multi-billion-dollar hedge fund firm. Now an independent trader and publisher at The Felder Report.

Tischendorf Letter - Trading High Potential Stocks - 18 years trading experience

PM/Securites Analyst of Small-Caps only. Investment/Management Style: Thematic- Scale Trader: Arrive early in a stock before the party guests do and implement a pay as you go strategy.

We are a diverse Informational Trading Service that focuses in US equities. Our methodology is a combination of Technical Analysis, Macro factors, Catalysts and Fundamental Analysis. http://www.PrecisionTrade365.com

Trader, Editor of the Finance Trends Newsletter. Signup ▼

Biotech

I have been investing in the volatile market of Biotechnology for about 16 years now. Catalysts are what move these Bio's the most and that's the strategy along with trading technical bottoms. Let's have some fun making consistent gains!

Trading/Investing for over 11 years with a heavy emphasis on long/small cap biotech ideas. Recent research in regenerative and nano medicine has led me to the belief that we are in the beginnings of a major bull market in this sector.

My incredibly smart wife one day suggested that I stop talking to the TV on how to trade and to use my knowledge instead to help others. So, here I am.

Renaissance Capital provides pre-IPO research and global IPO market analytics to institutional investors. The firm manages portfolios of unseasoned equities through the Renaissance IPO ETF (IPO) and the Renaissance International IPO ETF (IPOS).

Always stop your losses quickly. #SarcasmAlert

Expat Canadian - Permanent Resident of Chile

Now in beta: a free service that tracks North American stocks with insider buying and selling. Tweets are not investment advice and subject to our disclaimer on our website.